Skip to main content

Advertisement

SpringerLink
Log in

Combining PCI and CABG: the Role of Hybrid Revascularization

  • Interventional Cardiology (S Rao, Section Editor)
  • Published:
Current Cardiology Reports Aims and scope Submit manuscript

Abstract

Hybrid coronary revascularization combines the benefits of both percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG) in the treatment of multivessel coronary artery disease (CAD) by combining the benefits of the LIMA-to-LAD graft and drug eluting stent (DES) to non-LAD regions. Through this approach, a patient receives the long-term benefit of the LIMA graft and avoids the morbidity of a full sternotomy and saphenous vein grafts. Available data related to outcomes following hybrid revascularization is limited to small studies. In this review we seek to provide an overview of hybrid revascularization in the era of modern drug eluting stent technology, discuss appropriate patient selection, and comment on future trial design. Additionally, we review the recent literature pertaining to the hybrid approach.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Angelini GD, Wilde P, Salerno TA, Bosco G, Calafiore AM. Integrated left small thoracotomy and angioplasty for multivessel coronary artery revascularisation. Lancet. 1996;347(9003):757–8.

    Article  PubMed  CAS  Google Scholar 

  2. Loop FD, Lytle BW, Cosgrove DM, et al. Influence of the internal-mammary-artery graft on 10-year survival and other cardiac events. N Engl J Med. 1986;314(1):1–6.

    Article  PubMed  CAS  Google Scholar 

  3. Yeung AC, Leon MB, Jain A, et al. Clinical evaluation of the resolute zotarolimus-eluting coronary stent system in the treatment of de novo lesions in native coronary arteries. J Am Coll Cardiol. 2011;57(17):1778–83.

    Article  PubMed  Google Scholar 

  4. Puskas JD, Williams WH, Mahoney EM, et al. Off-pump vs conventional coronary artery bypass grafting: early and 1-year graft patency, cost, and quality-of-life outcomes: a randomized trial. JAMA. 2004;291(15):1841–9.

    Article  PubMed  CAS  Google Scholar 

  5. Weisz G, Leon MB, Holmes DR, et al. Five-year follow-up after sirolimus-eluting stent implantation. J Am Coll Cardiol. 2009;53(17):1488–97.

    Article  PubMed  CAS  Google Scholar 

  6. Alfonso F, Perez-Vizcayno M-J, Hernandez R, et al. Sirolimus-eluting stents versus bare-metal stents in patients with in-stent restenosis: results of a pooled analysis of two randomized studies. Catheter Cardiovasc Interv. 2008;72(4):459–67.

    Article  PubMed  Google Scholar 

  7. Caracciolo EA, Davis KB, Sopko G, et al. Comparison of surgical and medical group survival in patients with left main equivalent coronary artery disease. Long-term CASS experience. Circulation. 1995;91(9):2335–44.

    Article  PubMed  CAS  Google Scholar 

  8. Mauri L, Orav EJ, Kuntz RE. Late loss in lumen diameter and binary restenosis for drug-eluting stent comparison. Circulation. 2005;111(25):3435–42.

    Article  PubMed  Google Scholar 

  9. •• Leacche M, Byrne J, Solenkova N, Reagan B, et al. Comparison of 30-day outcomes of coronary artery bypass grafting surgery verus hybrid coronary revascularization stratified by SYNTAX and euroSCORE. J Thorac Cardiovasc Surg. 2012;1–10. This study identifies patient populations best suited for hybrid therapy using SYNTAX and euroSCORE.

  10. Bachinsky WB, Abdelsalam M, Boga G, Kiljanek L, Mumtaz M, McCarty C. Comparative study of same sitting hybrid coronary artery revascularization versus off-pump coronary artery bypass in multivessel coronary artery disease. J Interv Cardiol. 2012;25(5):460–8. doi:10.1111/j.1540-8183.2012.00752.x.

    Article  PubMed  Google Scholar 

  11. Rab ST, Douglas Jr JS, Lyons E, et al. Hybrid coronary revascularization for the treatment of left main coronary stenosis: a feasibility study. Cathet Cardiovasc Interv. 2011;80(2):238–44.

    Article  Google Scholar 

  12. Fedakar A, Tasar M, Rabus MB, Alsalehi S, Toker ME, Balkanay M. Hybrid coronary revascularization for the treatment of left main coronary artery disease in high-risk patients. Heart Surg Forum. 2012;15(1):E51–5.

    Article  PubMed  Google Scholar 

  13. • Halkos ME, Vassiliades TA, Douglas JS, et al. Hybrid coronary revascularization versus off-pump coronary artery bypass grafting for the treatment of multivessel coronary artery disease. Ann Thorac Surg. 2011;92(5):1695–702. This is the largest published series to date, concluding that Hybrid therapy is safe and effective in appropriately selected patients.

    Article  PubMed  Google Scholar 

  14. Hu S-S, Xiong H, Zheng Z, et al. Midterm outcomes of simultaneous hybrid coronary artery revascularization for left main coronary artery disease. Heart Surg Forum. 2012;15(1):E18–22.

    Article  PubMed  Google Scholar 

  15. The BARI Investigators. The final 10-year follow-up results from the BARI randomized trial. J Am Coll Cardiol. 2007;49(15):1600–1606.

    Google Scholar 

  16. Serruys PW, Morice M-C, Kappetein AP, et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med. 2009;360(10):961–72.

    Article  PubMed  CAS  Google Scholar 

  17. Willerson JT. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. Circulation. 1996;94(6):1194.

    Article  PubMed  CAS  Google Scholar 

  18. The BARI Investigators. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. The Bypass Angioplasty Revascularization Investigation (BARI) investigators. N Engl J Med. 1996;335(4):217–225.

    Google Scholar 

  19. Alexander JH, Hafley G, Harrington RA, et al. Efficacy and safety of edifoligide, an E2F transcription factor decoy, for prevention of vein graft failure following coronary artery bypass graft surgery: PREVENT IV: a randomized controlled trial. JAMA. 2005;294(19):2446–54.

    Article  PubMed  Google Scholar 

  20. Hoffman SN, TenBrook JA, Wolf MP, Pauker SG, Salem DN, Wong JB. A meta-analysis of randomized controlled trials comparing coronary artery bypass graft with percutaneous transluminal coronary angioplasty: one- to eight-year outcomes. J Am Coll Cardiol. 2003;41(8):1293–304.

    Article  PubMed  Google Scholar 

  21. Mercado N, Wijns W, Serruys PW, et al. One-year outcomes of coronary artery bypass graft surgery versus percutaneous coronary intervention with multiple stenting for multisystem disease: a meta-analysis of individual patient data from randomized clinical trials. J Thorac Cardiovasc Surg. 2005;130(2):512–9.

    Article  PubMed  Google Scholar 

  22. Yan TD, Padang R, Poh C, et al. Drug-eluting stents versus coronary artery bypass grafting for the treatment of coronary artery disease: a meta-analysis of randomized and nonrandomized studies. J Thorac Cardiovasc Surg. 2011;141(5):1134–44.

    Article  PubMed  Google Scholar 

  23. Zhao DX, Leacche M, Balaguer JM, et al. Routine intraoperative completion angiography after coronary artery bypass grafting and 1-stop hybrid revascularization. J Am Coll Cardiol. 2009;53(3):232–41.

    Article  PubMed  Google Scholar 

  24. Us MH, Basaran M, Yilmaz M, et al. Hybrid coronary revascularization in high-risk patients. Tex Heart Inst J. 2006;33(4):458–62.

    PubMed  Google Scholar 

  25. Umakanthan R, Leacche M, Zhao DX, Gallion AH, Mishra PC, Byrne JG. Hybrid options for treating cardiac disease. Semin Thorac Cardiovasc Surg. 2011;23(4):274–80.

    Article  PubMed  Google Scholar 

  26. Lee M-S, Faxon DP. Revascularization of left main coronary artery disease. Cardiol Rev. 2011;19(4):177–83.

    Article  PubMed  Google Scholar 

  27. Balaguer JM, Umakanthan R, Leacche M, Byrne JG. Minimally invasive cardiac surgery. Curr Probl Surg. 2012;49(9):529–49.

    Article  PubMed  Google Scholar 

  28. Narasimhan S, Srinivas VS, DeRose Jr JJ. Hybrid coronary revascularization. Cardiol Rev. 2011;19(3):101–7.

    Article  PubMed  Google Scholar 

  29. de Canniere D, Jansens JL, Goldschmidt-Clermont P, Barvais L, Decroly P, Stoupel E. Combination of minimally invasive coronary bypass and percutaneous transluminal coronary angioplasty in the treatment of double-vessel coronary disease: two-year follow-up of a new hybrid procedure compared with “on-pump” double bypass grafting. Am Heart J. 2001;142(4):563–70.

    Article  PubMed  Google Scholar 

  30. Bonatti J, Lehr EJ, Vesely M, et al. Hybrid coronary revascularization – techniques and outcome. Eur Surg. 2011;43(4):198–204.

    Article  Google Scholar 

  31. Lloyd CT, Calafiore AM, Wilde P, et al. Integrated left anterior small thoracotomy and angioplasty for coronary artery revascularization. Ann Thorac Surg. 1999;68(3):908–11. discussion 911–2.

    Article  PubMed  CAS  Google Scholar 

  32. Lewis BS, Porat E, Halon DA, et al. Same-day combined coronary angioplasty and minimally invasive coronary surgery. Am J Cardiol. 1999;84(10):1246–7. A8.

    Article  PubMed  CAS  Google Scholar 

  33. Zenati M, Cohen HA, Griffith BP. Alternative approach to multivessel coronary disease with integrated coronary revascularization. J Thorac Cardiovasc Sur. 1999;117(3):439–44. discussion 444–6.

    Article  CAS  Google Scholar 

  34. Wittwer T, Cremer J, Klima U, Wahlers T, Haverich A. Myocardial “hybrid” revascularization: intermediate results of an alternative approach to multivessel coronary artery disease. J Thorac Cardiovasc Sur. 1999;118(4):766–7.

    Article  CAS  Google Scholar 

  35. Isomura T, Suma H, Horii T, Sato T, Kobashi T, Kanemitsu H. Minimally invasive coronary artery revascularization: off-pump bypass grafting and the hybrid procedure. Ann Thorac Surg. 2000;70(6):2017–22.

    Article  PubMed  CAS  Google Scholar 

  36. Presbitero P, Nicolini F, Maiello L, et al. “Hybrid” percutaneous and surgical coronary revascularization: selection criteria from a single-center experience. Ital Heart J. 2001;2(5):363–8.

    PubMed  CAS  Google Scholar 

  37. Cisowski M, Morawski W, Drzewiecki J, et al. Integrated minimally invasive direct coronary artery bypass grafting and angioplasty for coronary artery revascularization. Eur J Cardiothorac Surg. 2002;22(2):261–5.

    Article  PubMed  Google Scholar 

  38. Stahl KD, Boyd WD, Vassiliades TA, Karamanoukian HL. Hybrid robotic coronary artery surgery and angioplasty in multivessel coronary artery disease. Ann Thorac Surg. 2002;74(4):S1358–62.

    Article  PubMed  Google Scholar 

  39. Riess F-C, Bader R, Kremer P, et al. Coronary hybrid revascularization from January 1997 to January 2001: a clinical follow-up. Ann Thorac Surg. 2002;73(6):1849–55.

    Article  PubMed  Google Scholar 

  40. Lee MS, Wilentz JR, Makkar RR, et al. Hybrid revascularization using percutaneous coronary intervention and robotically assisted minimally invasive direct coronary artery bypass surgery. J Invasive Cardiol. 2004;16(8):419–25.

    PubMed  Google Scholar 

  41. Davidavicius G, Van Praet F, Mansour S, et al. Hybrid revascularization strategy: a pilot study on the association of robotically enhanced minimally invasive direct coronary artery bypass surgery and fractional-flow-reserve-guided percutaneous coronary intervention. Circulation. 2005;112(9 Suppl):I317–22.

    PubMed  Google Scholar 

  42. Kiaii B, McClure RS, Kostuk WJ, et al. Concurrent robotic hybrid revascularization using an enhanced operative suite. Chest. 2005;128(6):4046–8.

    Article  PubMed  Google Scholar 

  43. Kappetein AP, Feldman TE, Mack MJ, et al. Comparison of coronary bypass surgery with drug-eluting stenting for the treatment of left main and/or three-vessel disease: 3-year follow-up of the SYNTAX trial. Eur Heart J. 2011;32(17):2125–34.

    Article  PubMed  Google Scholar 

  44. Katz MR, Van Praet F, de Canniere D, et al. Integrated coronary revascularization: percutaneous coronary intervention plus robotic totally endoscopic coronary artery bypass. Circulation. 2006;114(1 Suppl):I473–6.

    PubMed  Google Scholar 

  45. Vassiliades TAJ, Douglas JS, Morris DC, et al. Integrated coronary revascularization with drug-eluting stents: immediate and seven-month outcome. J Thorac Cardiovasc Surg. 2006;131(5):956–62.

    Article  PubMed  Google Scholar 

  46. Gilard M, Bezon E, Cornily JC, et al. Same-day combined percutaneous coronary intervention and coronary artery surgery. Cardiology. 2007;108(4):363–7.

    Article  PubMed  Google Scholar 

  47. Kon ZN, Brown EN, Tran R, et al. Simultaneous hybrid coronary revascularization reduces postoperative morbidity compared with results from conventional off-pump coronary artery bypass. J Thorac Cardiovasc Surg. 2008;135(2):367–75.

    Article  PubMed  Google Scholar 

  48. Bonatti J, Schachner T, Bonaros N, et al. Simultaneous hybrid coronary revascularization using totally endoscopic left internal mammary artery bypass grafting and placement of rapamycin eluting stents in the same interventional session. The COMBINATION pilot study. Cardiology. 2008;110(2):92–5.

    Article  PubMed  CAS  Google Scholar 

  49. Reicher B, Poston RS, Mehra MR, et al. Simultaneous “hybrid” percutaneous coronary intervention and minimally invasive surgical bypass grafting: feasibility, safety, and clinical outcomes. Am Heart J. 2008;155(4):661–7.

    Article  PubMed  Google Scholar 

  50. Holzhey DM, Jacobs S, Mochalski M, et al. Minimally invasive hybrid coronary artery revascularization. Ann Thorac Surg. 2008;86(6):1856–60.

    Article  PubMed  Google Scholar 

  51. Hu S, Li Q, Gao P, et al. Simultaneous hybrid revascularization versus off-pump coronary artery bypass for multivessel coronary artery disease. Ann Thorac Surg. 2011;91(2):432–8.

    Article  PubMed  Google Scholar 

Download references

Disclosure

No potential conflicts of interest relevant to this article were reported.

Author information

Authors and Affiliations

  1. Vanderbilt Heart and Vascular Institute, 1215 21st Avenue South, Nashville, TN, 37232-8802, USA

    Kelly D. Green, Donald R. Lynch Jr., Tyffany P. Chen & David Zhao

  2. Vanderbilt Heart and Vascular Institute, Vanderbilt University Medical Center, 1215 21st Avenue South, 5209 Medical Center East, Nashville, TN, 37232-8802, USA

    David Zhao

Authors
  1. Kelly D. Green
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Donald R. Lynch Jr.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Tyffany P. Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. David Zhao
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to David Zhao.

Additional information

This article is part of the Topical Collection on Interventional Cardiology

Rights and permissions

Reprints and permissions

About this article

Cite this article

Green, K.D., Lynch, D.R., Chen, T.P. et al. Combining PCI and CABG: the Role of Hybrid Revascularization. Curr Cardiol Rep 15, 351 (2013). https://doi.org/10.1007/s11886-013-0351-9

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11886-013-0351-9

Keywords

Search

Navigation